Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome

被引:9
|
作者
Xie, Wenhui [1 ]
Huang, Hong [1 ]
Zhang, Zhuoli [1 ]
机构
[1] Peking Univ First Hosp, Dept Rheumatol & Clin Immunol, Beijing 100034, Peoples R China
关键词
D O I
10.1136/annrheumdis-2020-217854
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Off-label use of medicines
    C. A. Yeung
    British Dental Journal, 2017, 222 : 495 - 496
  • [42] The off-label uses profile of tofacitinib in systemic rheumatic diseases
    Zhao, Zichu
    Ye, Cong
    Dong, Lingli
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 83
  • [43] Off-Label Use Reimbursement
    Cohen, Joshua
    Wilson, Andrew
    Faden, Laura
    FOOD AND DRUG LAW JOURNAL, 2009, 64 (02) : 391 - 403
  • [45] A Hemorrhage of Off-Label Use
    Karkouti, Keyvan
    Levy, Jerrold H.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (05) : 339 - 339
  • [46] QUETIAPINE OFF-LABEL USE
    Levin, R.
    Cosmatos, I
    Dieck, G.
    Reifsnyder, J.
    VALUE IN HEALTH, 2016, 19 (07) : A522 - A522
  • [47] Methylphenidate Off-label Use
    Trenque, T.
    DRUG SAFETY, 2012, 35 (10) : 891 - 891
  • [48] Off-label use of vaccines
    Neels, Pieter
    Southern, James
    Abramson, Jon
    Duclos, Philippe
    Hombach, Joachim
    Marti, Melanie
    Fitzgerald-Husek, Alanna
    Fournier-Caruana, Jacqueline
    Hanquet, Germaine
    VACCINE, 2017, 35 (18) : 2329 - 2337
  • [49] Off-label use in neurology
    Diener, HC
    AKTUELLE NEUROLOGIE, 2002, 29 (08) : 379 - 381
  • [50] A Hemorrhage of Off-Label Use
    Avorn, Jerry
    Kesselheim, Aaron
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 566 - 567